U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H4N2
Molecular Weight 80.088
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PYRAZINE

SMILES

C1=CN=CC=N1

InChI

InChIKey=KYQCOXFCLRTKLS-UHFFFAOYSA-N
InChI=1S/C4H4N2/c1-2-6-4-3-5-1/h1-4H

HIDE SMILES / InChI

Molecular Formula C4H4N2
Molecular Weight 80.088
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
2004-02
Total synthesis of (+/-)-alantrypinone by hetero Diels-Alder reaction.
2004-01-09
Redox reactions of the pyranopterin system of the molybdenum cofactor.
2004-01
Anion control of the self-assembly of 2,3-diarylpyrazines with silver(I) salts.
2003-12-29
Symmetrical electron-deficient materials incorporating azaheterocycles.
2003-11-21
Dinuclear versus mononuclear ruthenium(II) and osmium(II) complexes as potent mediators of glucose oxidase; crystal structure of [OsCl(4,4'-bpy)(bpy)2]BF4.
2003-11
Pyrazine analogues of dipyrrolylquinoxalines.
2003-10-30
Synthesis and pharmacological evaluation of (Z)-9-(heteroarylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes: thiophene analogues as potent norepinephrine transporter inhibitors.
2003-10-20
Novel synthetic approach to 6,7-dihydro-5H-imidazo[1,5-a]-pyrazin-8-ones.
2003-10-16
Coordination polyhedron and chemical vapor deposition of Cu(hfacac)2(t-BuNH2).
2003-10-06
Growth and angiogenesis are inhibited in vivo in developing tissues by pyrazine and its derivatives.
2003-10
Generation of group-specific antibodies against sulfonamides.
2003-09-24
Long-range ferromagnetic ordering in two-dimensional coordination polymers Co[N(CN)2]2(L) [L = pyrazine dioxide (pzdo) and 2-methyl pyrazine dioxide (mpdo)] with dual mu- and mu3-[N(CN)2] bridges.
2003-08-25
Silver(I) coordination chemistry of 2,6-diarylpyrazines. Pi-stacking, anion coordination, and steric control.
2003-08-25
Capsule-like assemblies in polar solvents.
2003-08-22
Ferromagnetic ordering and metamagnetism in malonate bridged 3D diamond-like and honeycomb-like networks: [Cu(mal)(DMF)]n and [[Cu(mal)(0.5pyz)].H2O]n (mal = Malonate Dianion, DMF = N,N-dimethylformamide, pyz = Pyrazine).
2003-08-11
Semisynthesis of heterocyclic analogues of squamocin, a cytotoxic annonaceous acetogenin, by an unusual oxidative decarboxylation reaction.
2003-08-05
Extended quantum critical phase in a magnetized spin-1/2 antiferromagnetic chain.
2003-07-18
Synthesis, complexation, and coordination oligomerization of 1,8-pyrazine-capped 5,12-dioxocyclams.
2003-07-14
Synthesis and properties of V6O16CU(C4H4N2)2 x (H2O)(0.22(1)): charge density matching of a metal-segregated layer structure.
2003-07-14
DOTTADs--readily made novel metal ligands with multivariant functionality--trans-DOTTADs and semi-DOTTADs.
2003-06-21
An overview of inhibitors of Na(+)/H(+) exchanger.
2003-06
Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery.
2003-05-16
Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
2003-05-08
Chemoenzymatic synthesis of aroma active 5,6-dihydro- and tetrahydropyrazines from aliphatic acyloins produced by baker's yeast.
2003-05-07
Two-dimensional homochiral manganese(II)-azido frameworks incorporating an achiral ligand: partial spontaneous resolution and weak ferromagnetism.
2003-04-30
Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides.
2003-04-15
Spontaneously organizing metal connectors as supramolecular structure directors of two- and three-dimensional organometallic assemblies.
2003-04-14
A study by ultraviolet spectroscopy on the self-association of diazines in aqueous solution.
2003-04
New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
2003-03-27
[Cu(H4C3N2S)Cl2](n), an unprecedented diazole-bridged one-dimensional copper halide: synthesis, structure, and magnetic properties.
2003-03-24
Novel pyrazine metabolites found in polymyxin biosynthesis by Paenibacillus polymyxa.
2003-03-14
Assembly of discrete, one-, two-, and three-dimensional silver(I) supramolecular complexes containing encapsulated acetylide dianion with nitrogen-donor spacers.
2003-03-10
Infrared activity of symmetric bridging ligand modes in pyrazine-bridged hexaruthenium mixed-valence clusters.
2003-02-24
Synthesis, biological evaluation and DNA binding properties of novel mono and bisnaphthalimides.
2003-02-21
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
2003-02-20
Synthesis, structure-activity relationship and in vitro evaluation of coelenterazine and coelenteramine derivatives as inhibitors of lipid peroxidation.
2003-02
A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid.
2003-01-27
In situ co-crystallisation as a tool for low-temperature crystal engineering.
2003-01-21
X- and W-band EPR and Q-band ENDOR studies of the flavin radical in the Na+ -translocating NADH:quinone oxidoreductase from Vibrio cholerae.
2003-01-08
Augmentation of H2 photoproduction in Rhodopseudomonas palustris by N-heterocyclic aromatic compounds.
2003-01
Preparing functional bis(indole) pyrazine by stepwise cross-coupling reactions: an efficient method to construct the skeleton of dragmacidin D.
2002-12-27
Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
2002-12-05
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
2002-12
2-pyrazinylnitrene and 4-pyrimidylnitrene. Ring expansion to 1,3,5-triazacyclohepta-1,2,4,6-tetraene and ring opening to (2-Isocyanovinyl)carbodiimide.
2002-11-29
Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
2002-10-31
Solid-state ligand dynamics in interpenetrating Mn[N(CN)(2)](2)(pyrazine): a neutron spectroscopy study.
2002-10-23
Kinetics and mechanism of the formation of nitroprusside from aquapentacyanoferrate(III) and NO: complex formation controlled by outer-sphere electron transfer.
2002-10-21
Volatile compounds of headspace gas in the Japanese fish sauce ishiru.
2002-10
Amitriptyline has a dual effect on the conductive properties of the epithelial Na channel.
2002-10
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:44:41 GMT 2025
Edited
by admin
on Mon Mar 31 18:44:41 GMT 2025
Record UNII
2JKE371789
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FEMA NO. 4015
Preferred Name English
PYRAZINE
FHFI   MI  
Systematic Name English
1,4-DIAZINE
Systematic Name English
P-DIAZINE
Common Name English
PYRAZINE [MI]
Common Name English
PIAZINE
Common Name English
PYRAZINE [FHFI]
Common Name English
PARADIAZINE
Systematic Name English
1,4-DIAZABENZENE
Systematic Name English
NSC-400221
Code English
Classification Tree Code System Code
JECFA EVALUATION PYRAZINE
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
Code System Code Type Description
SMS_ID
300000045822
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
PUBCHEM
9261
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
NSC
400221
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-027-6
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
CHEBI
30953
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
FDA UNII
2JKE371789
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
WIKIPEDIA
PYRAZINE
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
MERCK INDEX
m9338
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY Merck Index
CAS
290-37-9
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID8049410
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY
JECFA MONOGRAPH
728
Created by admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
PRIMARY